Paola De Bartolo

Prof. Dr. Paola De Bartolo

Marconi University, Rome, Lazio, Italy
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
ANAnnalisa Nobili
Annalisa Nobili
ELEmanuele Claudio Latagliata
Emanuele Claudio Latagliata
Maria ViscomiMaria Viscomi
Maria Viscomi
VCVirve Cavallucci
Virve Cavallucci
DCDebora Cutuli
Debora Cutuli
MDMarcello D’amelio
Marcello D’amelio
Alterations of the dopaminergic (DAergic) system are frequently reported in Alzheimer’s disease (AD) patients and are commonly linked to cognitive and non-cognitive symptoms. However, the cause of DAergic system dysfunction in AD remains to be elucidated. We investigated alterations of the midbrain DAergic system in the Tg2576 mouse model of AD, overexpressing a mutated human amyloid precursor protein (APPswe). Here, we found an age-dependent DAergic neuron loss in the ventral tegmental area (VTA) at pre-plaque stages, although substantia nigra pars compacta (SNpc) DAergic neurons were intact. The selective VTA DAergic neuron degeneration results in lower DA outflow in the hippocampus and nucleus accumbens (NAc) shell. The progression of DAergic cell death correlates with impairments in CA1 synaptic plasticity, memory performance and food reward processing. We conclude that in this mouse model of AD, degeneration of VTA DAergic neurons at pre-plaque stages contributes to memory deficits and dysfunction of reward processing.

1 October 2009 in Brain Research Reviews
Verified
Journal Article
Closed access
LPLaura Petrosini
Laura Petrosini
PBPaola De Bartolo
Paola De Bartolo
FFFrancesca Foti
Francesca Foti
FGFrancesca Gelfo
Francesca Gelfo
DCDebora Cutuli
Debora Cutuli
LMLaura Mandolesi
Laura Mandolesi

27 February 2013 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
Anna Rita FetoniAnna Rita Fetoni
Anna Rita Fetoni
PBPaola De Bartolo
Paola De Bartolo
SESara Letizia Maria Eramo
Sara Letizia Maria Eramo
RRRolando Rolesi
Rolando Rolesi
FPFabiola Paciello
Fabiola Paciello
DTDiana Troiani
Diana Troiani
This study addresses the relationship between cochlear oxidative damage and auditory cortical injury in a rat model of repeated noise exposure. To test the effect of increased antioxidant defenses, a water-soluble coenzyme Q10analog (Qter) was used. We analyzed auditory function, cochlear oxidative stress, morphological alterations in auditory cortices and cochlear structures, and levels of coenzymes Q9and Q10(CoQ9and CoQ10, respectively) as indicators of endogenous antioxidant capability. We report three main results. First, hearing loss and damage in hair cells and spiral ganglion was determined by noise-induced oxidative stress. Second, the acoustic trauma altered dendritic morphology and decreased spine number of II–III and V–VI layer pyramidal neurons of auditory cortices. Third, the systemic administration of the water-soluble CoQ10analog reduced oxidative-induced cochlear damage, hearing loss, and cortical dendritic injury. Furthermore, cochlear levels of CoQ9and CoQ10content increased. These findings indicate that antioxidant treatment restores auditory cortical neuronal morphology and hearing function by reducing the noise-induced redox imbalance in the cochlea and the deafferentation effects upstream the acoustic pathway.

29 May 2012 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
PBPaola Bossù
Paola Bossù
DCDebora Cutuli
Debora Cutuli
IPIlaria Palladino
Ilaria Palladino
PCPaola Caporali
Paola Caporali
FAFrancesco Angelucci
Francesco Angelucci
LPLaura Petrosini
Laura Petrosini
Systemic inflammation might cause neuronal damage and sustain neurodegenerative diseases and behavior impairment, with the participation of pro-inflammatory cytokines, like tumor necrosis factor (TNF)-α and interleukin (IL)-18. However, the potential contribution of these cytokines to behavioral impairment in the long-term period has not been fully investigated.

1 April 2020 in Sleep Medicine Reviews
Verified
Journal Article
Closed access
VBValeria Bacaro
Valeria Bacaro
FBFee Benz
Fee Benz
APAndrea Pappaccogli
Andrea Pappaccogli
PBPaola De Bartolo
Paola De Bartolo
AJAnna F. Johann
Anna F. Johann
CBChiara Baglioni
Chiara Baglioni

25 August 2014 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
DCDebora Cutuli
Debora Cutuli
PBPaola De Bartolo
Paola De Bartolo
PCPaola Caporali
Paola Caporali
Daniela LaricchiutaDaniela Laricchiuta
Daniela Laricchiuta
FFFrancesca Foti
Francesca Foti
LPLaura Petrosini
Laura Petrosini
As major components of neuronal membranes, omega-3 polyunsaturated acids (n-3 PUFA) exhibit a wide range of regulatory functions, modulating from synaptic plasticity to neuroinflammation, from oxidative stress to neuroprotection. Recent human and animal studies indicated the n-3 PUFA neuroprotective properties in aging, with a clear negative correlation between n-3 PUFA levels and hippocampal deficits. The present multidimensional study was aimed at associating cognition, hippocampal neurogenesis, volume, neurodegeneration and metabolic correlates to verify n-3 PUFA neuroprotective effects in aging. To this aim 19 month-old mice were given n-3 PUFA mixture, or olive oil or no dietary supplement for 8 weeks during which hippocampal-dependent mnesic functions were tested. At the end of behavioral testing morphological and metabolic correlates were analyzed. n-3 PUFA supplemented aged mice exhibited better object recognition memory, spatial and localizatory memory, and aversive response retention, without modifications in anxiety levels in comparison to controls. These improved hippocampal cognitive functions occurred in the context of an enhanced cellular plasticity and a reduced neurodegeneration. In fact, n-3 PUFA supplementation increased hippocampal neurogenesis and dendritic arborization of newborn neurons, volume, neuronal density and microglial cell number, while it decreased apoptosis, astrocytosis and lipofuscin accumulation in the hippocampus. The increased levels of some metabolic correlates (blood Acetyl-L-Carnitine and brain n-3 PUFA concentrations) found in n-3 PUFA supplemented mice also pointed towards an effective neuroprotection. On the basis of the present results n-3 PUFA supplementation appears to be a useful tool in health promotion and cognitive decline prevention during aging.